Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-013743

Director sold 2,000 shares at $242.25 ($484,500)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FARRELL PETER C Director 2025-05-07 Sale 10b5-1 −2,000 $242.25 $484,500 71,218 D: show line 1 in the form
Open-market sales · 2,000 sh · avg $242.25 · $484,500
Loading xslF345X05/form4.xml…